Global Mesalamine API Market Growth 2025-2031
The global Mesalamine API market size is predicted to grow from US$ 188 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Mesalamine was approved for medical use in the United States in 1987. Mesalamine, also known as mesalazine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
LP Information, Inc. (LPI) ' newest research report, the “Mesalamine API Industry Forecast” looks at past sales and reviews total world Mesalamine API sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalamine API sales for 2025 through 2031. With Mesalamine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalamine API industry.
This Insight Report provides a comprehensive analysis of the global Mesalamine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalamine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalamine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalamine API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalamine API.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mesalamine API market?
What factors are driving Mesalamine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalamine API market opportunities vary by end market size?
How does Mesalamine API break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Mesalamine was approved for medical use in the United States in 1987. Mesalamine, also known as mesalazine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
LP Information, Inc. (LPI) ' newest research report, the “Mesalamine API Industry Forecast” looks at past sales and reviews total world Mesalamine API sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalamine API sales for 2025 through 2031. With Mesalamine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalamine API industry.
This Insight Report provides a comprehensive analysis of the global Mesalamine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalamine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalamine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalamine API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalamine API.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity ? 97 %
- Purity ? 98 %
- Purity ? 99 %
- Tablets
- Capsules
- Granule
- Suppository
- Enema
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PharmaZell
- Syntese A/S
- Cambrex Corporation
- Divis Laboratories
- Chemi SpA
- Ipca Laboratories
- Hangzhou Brother
- Lianyungang Fengheng Biopharm
- Lasa Loboratory
- Corden Pharma Bergamo
- Erregierre SpA
- CTX Lifescience
- Ishita Active Pharma Ingredients
- YC Biotech (Jiangsu)
- Xinxiang Tianfeng Fine Chemical
What is the 10-year outlook for the global Mesalamine API market?
What factors are driving Mesalamine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalamine API market opportunities vary by end market size?
How does Mesalamine API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalamine API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mesalamine API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mesalamine API by Country/Region, 2020, 2024 & 2031
2.2 Mesalamine API Segment by Type
2.2.1 Purity ? 97 %
2.2.2 Purity ? 98 %
2.2.3 Purity ? 99 %
2.3 Mesalamine API Sales by Type
2.3.1 Global Mesalamine API Sales Market Share by Type (2020-2025)
2.3.2 Global Mesalamine API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mesalamine API Sale Price by Type (2020-2025)
2.4 Mesalamine API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalamine API Sales by Application
2.5.1 Global Mesalamine API Sale Market Share by Application (2020-2025)
2.5.2 Global Mesalamine API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mesalamine API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mesalamine API Breakdown Data by Company
3.1.1 Global Mesalamine API Annual Sales by Company (2020-2025)
3.1.2 Global Mesalamine API Sales Market Share by Company (2020-2025)
3.2 Global Mesalamine API Annual Revenue by Company (2020-2025)
3.2.1 Global Mesalamine API Revenue by Company (2020-2025)
3.2.2 Global Mesalamine API Revenue Market Share by Company (2020-2025)
3.3 Global Mesalamine API Sale Price by Company
3.4 Key Manufacturers Mesalamine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalamine API Product Location Distribution
3.4.2 Players Mesalamine API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAMINE API BY GEOGRAPHIC REGION
4.1 World Historic Mesalamine API Market Size by Geographic Region (2020-2025)
4.1.1 Global Mesalamine API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mesalamine API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mesalamine API Market Size by Country/Region (2020-2025)
4.2.1 Global Mesalamine API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mesalamine API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalamine API Sales Growth
4.4 APAC Mesalamine API Sales Growth
4.5 Europe Mesalamine API Sales Growth
4.6 Middle East & Africa Mesalamine API Sales Growth
5 AMERICAS
5.1 Americas Mesalamine API Sales by Country
5.1.1 Americas Mesalamine API Sales by Country (2020-2025)
5.1.2 Americas Mesalamine API Revenue by Country (2020-2025)
5.2 Americas Mesalamine API Sales by Type (2020-2025)
5.3 Americas Mesalamine API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalamine API Sales by Region
6.1.1 APAC Mesalamine API Sales by Region (2020-2025)
6.1.2 APAC Mesalamine API Revenue by Region (2020-2025)
6.2 APAC Mesalamine API Sales by Type (2020-2025)
6.3 APAC Mesalamine API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalamine API by Country
7.1.1 Europe Mesalamine API Sales by Country (2020-2025)
7.1.2 Europe Mesalamine API Revenue by Country (2020-2025)
7.2 Europe Mesalamine API Sales by Type (2020-2025)
7.3 Europe Mesalamine API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalamine API by Country
8.1.1 Middle East & Africa Mesalamine API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mesalamine API Revenue by Country (2020-2025)
8.2 Middle East & Africa Mesalamine API Sales by Type (2020-2025)
8.3 Middle East & Africa Mesalamine API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalamine API
10.3 Manufacturing Process Analysis of Mesalamine API
10.4 Industry Chain Structure of Mesalamine API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalamine API Distributors
11.3 Mesalamine API Customer
12 WORLD FORECAST REVIEW FOR MESALAMINE API BY GEOGRAPHIC REGION
12.1 Global Mesalamine API Market Size Forecast by Region
12.1.1 Global Mesalamine API Forecast by Region (2026-2031)
12.1.2 Global Mesalamine API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mesalamine API Forecast by Type (2026-2031)
12.7 Global Mesalamine API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalamine API Product Portfolios and Specifications
13.1.3 PharmaZell Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalamine API Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalamine API Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalamine API Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalamine API Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalamine API Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalamine API Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalamine API Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalamine API Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalamine API Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalamine API Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalamine API Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalamine API Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalamine API Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalamine API Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalamine API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mesalamine API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mesalamine API by Country/Region, 2020, 2024 & 2031
2.2 Mesalamine API Segment by Type
2.2.1 Purity ? 97 %
2.2.2 Purity ? 98 %
2.2.3 Purity ? 99 %
2.3 Mesalamine API Sales by Type
2.3.1 Global Mesalamine API Sales Market Share by Type (2020-2025)
2.3.2 Global Mesalamine API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mesalamine API Sale Price by Type (2020-2025)
2.4 Mesalamine API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalamine API Sales by Application
2.5.1 Global Mesalamine API Sale Market Share by Application (2020-2025)
2.5.2 Global Mesalamine API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mesalamine API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mesalamine API Breakdown Data by Company
3.1.1 Global Mesalamine API Annual Sales by Company (2020-2025)
3.1.2 Global Mesalamine API Sales Market Share by Company (2020-2025)
3.2 Global Mesalamine API Annual Revenue by Company (2020-2025)
3.2.1 Global Mesalamine API Revenue by Company (2020-2025)
3.2.2 Global Mesalamine API Revenue Market Share by Company (2020-2025)
3.3 Global Mesalamine API Sale Price by Company
3.4 Key Manufacturers Mesalamine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalamine API Product Location Distribution
3.4.2 Players Mesalamine API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAMINE API BY GEOGRAPHIC REGION
4.1 World Historic Mesalamine API Market Size by Geographic Region (2020-2025)
4.1.1 Global Mesalamine API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mesalamine API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mesalamine API Market Size by Country/Region (2020-2025)
4.2.1 Global Mesalamine API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mesalamine API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalamine API Sales Growth
4.4 APAC Mesalamine API Sales Growth
4.5 Europe Mesalamine API Sales Growth
4.6 Middle East & Africa Mesalamine API Sales Growth
5 AMERICAS
5.1 Americas Mesalamine API Sales by Country
5.1.1 Americas Mesalamine API Sales by Country (2020-2025)
5.1.2 Americas Mesalamine API Revenue by Country (2020-2025)
5.2 Americas Mesalamine API Sales by Type (2020-2025)
5.3 Americas Mesalamine API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalamine API Sales by Region
6.1.1 APAC Mesalamine API Sales by Region (2020-2025)
6.1.2 APAC Mesalamine API Revenue by Region (2020-2025)
6.2 APAC Mesalamine API Sales by Type (2020-2025)
6.3 APAC Mesalamine API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalamine API by Country
7.1.1 Europe Mesalamine API Sales by Country (2020-2025)
7.1.2 Europe Mesalamine API Revenue by Country (2020-2025)
7.2 Europe Mesalamine API Sales by Type (2020-2025)
7.3 Europe Mesalamine API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalamine API by Country
8.1.1 Middle East & Africa Mesalamine API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mesalamine API Revenue by Country (2020-2025)
8.2 Middle East & Africa Mesalamine API Sales by Type (2020-2025)
8.3 Middle East & Africa Mesalamine API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalamine API
10.3 Manufacturing Process Analysis of Mesalamine API
10.4 Industry Chain Structure of Mesalamine API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalamine API Distributors
11.3 Mesalamine API Customer
12 WORLD FORECAST REVIEW FOR MESALAMINE API BY GEOGRAPHIC REGION
12.1 Global Mesalamine API Market Size Forecast by Region
12.1.1 Global Mesalamine API Forecast by Region (2026-2031)
12.1.2 Global Mesalamine API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mesalamine API Forecast by Type (2026-2031)
12.7 Global Mesalamine API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalamine API Product Portfolios and Specifications
13.1.3 PharmaZell Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalamine API Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalamine API Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalamine API Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalamine API Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalamine API Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalamine API Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalamine API Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalamine API Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalamine API Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalamine API Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalamine API Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalamine API Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalamine API Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalamine API Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mesalamine API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mesalamine API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity ? 97 %
Table 4. Major Players of Purity ? 98 %
Table 5. Major Players of Purity ? 99 %
Table 6. Global Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 7. Global Mesalamine API Sales Market Share by Type (2020-2025)
Table 8. Global Mesalamine API Revenue by Type (2020-2025) & ($ million)
Table 9. Global Mesalamine API Revenue Market Share by Type (2020-2025)
Table 10. Global Mesalamine API Sale Price by Type (2020-2025) & (US$/kg)
Table 11. Global Mesalamine API Sale by Application (2020-2025) & (Tons)
Table 12. Global Mesalamine API Sale Market Share by Application (2020-2025)
Table 13. Global Mesalamine API Revenue by Application (2020-2025) & ($ million)
Table 14. Global Mesalamine API Revenue Market Share by Application (2020-2025)
Table 15. Global Mesalamine API Sale Price by Application (2020-2025) & (US$/kg)
Table 16. Global Mesalamine API Sales by Company (2020-2025) & (Tons)
Table 17. Global Mesalamine API Sales Market Share by Company (2020-2025)
Table 18. Global Mesalamine API Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Mesalamine API Revenue Market Share by Company (2020-2025)
Table 20. Global Mesalamine API Sale Price by Company (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Mesalamine API Producing Area Distribution and Sales Area
Table 22. Players Mesalamine API Products Offered
Table 23. Mesalamine API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalamine API Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Mesalamine API Sales Market Share Geographic Region (2020-2025)
Table 28. Global Mesalamine API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Mesalamine API Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Mesalamine API Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Mesalamine API Sales Market Share by Country/Region (2020-2025)
Table 32. Global Mesalamine API Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Mesalamine API Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Mesalamine API Sales by Country (2020-2025) & (Tons)
Table 35. Americas Mesalamine API Sales Market Share by Country (2020-2025)
Table 36. Americas Mesalamine API Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 38. Americas Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 39. APAC Mesalamine API Sales by Region (2020-2025) & (Tons)
Table 40. APAC Mesalamine API Sales Market Share by Region (2020-2025)
Table 41. APAC Mesalamine API Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 43. APAC Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 44. Europe Mesalamine API Sales by Country (2020-2025) & (Tons)
Table 45. Europe Mesalamine API Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 47. Europe Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Mesalamine API Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Mesalamine API Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 51. Middle East & Africa Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalamine API
Table 53. Key Market Challenges & Risks of Mesalamine API
Table 54. Key Industry Trends of Mesalamine API
Table 55. Mesalamine API Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalamine API Distributors List
Table 58. Mesalamine API Customer List
Table 59. Global Mesalamine API Sales Forecast by Region (2026-2031) & (Tons)
Table 60. Global Mesalamine API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Mesalamine API Sales Forecast by Country (2026-2031) & (Tons)
Table 62. Americas Mesalamine API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Mesalamine API Sales Forecast by Region (2026-2031) & (Tons)
Table 64. APAC Mesalamine API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Mesalamine API Sales Forecast by Country (2026-2031) & (Tons)
Table 66. Europe Mesalamine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Mesalamine API Sales Forecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Mesalamine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Mesalamine API Sales Forecast by Type (2026-2031) & (Tons)
Table 70. Global Mesalamine API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Mesalamine API Sales Forecast by Application (2026-2031) & (Tons)
Table 72. Global Mesalamine API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. PharmaZell Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 74. PharmaZell Mesalamine API Product Portfolios and Specifications
Table 75. PharmaZell Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 76. PharmaZell Main Business
Table 77. PharmaZell Latest Developments
Table 78. Syntese A/S Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 79. Syntese A/S Mesalamine API Product Portfolios and Specifications
Table 80. Syntese A/S Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Syntese A/S Main Business
Table 82. Syntese A/S Latest Developments
Table 83. Cambrex Corporation Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Corporation Mesalamine API Product Portfolios and Specifications
Table 85. Cambrex Corporation Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 86. Cambrex Corporation Main Business
Table 87. Cambrex Corporation Latest Developments
Table 88. Divis Laboratories Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 89. Divis Laboratories Mesalamine API Product Portfolios and Specifications
Table 90. Divis Laboratories Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 91. Divis Laboratories Main Business
Table 92. Divis Laboratories Latest Developments
Table 93. Chemi SpA Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemi SpA Mesalamine API Product Portfolios and Specifications
Table 95. Chemi SpA Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 96. Chemi SpA Main Business
Table 97. Chemi SpA Latest Developments
Table 98. Ipca Laboratories Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 99. Ipca Laboratories Mesalamine API Product Portfolios and Specifications
Table 100. Ipca Laboratories Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 101. Ipca Laboratories Main Business
Table 102. Ipca Laboratories Latest Developments
Table 103. Hangzhou Brother Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Brother Mesalamine API Product Portfolios and Specifications
Table 105. Hangzhou Brother Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 106. Hangzhou Brother Main Business
Table 107. Hangzhou Brother Latest Developments
Table 108. Lianyungang Fengheng Biopharm Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 109. Lianyungang Fengheng Biopharm Mesalamine API Product Portfolios and Specifications
Table 110. Lianyungang Fengheng Biopharm Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 111. Lianyungang Fengheng Biopharm Main Business
Table 112. Lianyungang Fengheng Biopharm Latest Developments
Table 113. Lasa Loboratory Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 114. Lasa Loboratory Mesalamine API Product Portfolios and Specifications
Table 115. Lasa Loboratory Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 116. Lasa Loboratory Main Business
Table 117. Lasa Loboratory Latest Developments
Table 118. Corden Pharma Bergamo Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 119. Corden Pharma Bergamo Mesalamine API Product Portfolios and Specifications
Table 120. Corden Pharma Bergamo Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 121. Corden Pharma Bergamo Main Business
Table 122. Corden Pharma Bergamo Latest Developments
Table 123. Erregierre SpA Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 124. Erregierre SpA Mesalamine API Product Portfolios and Specifications
Table 125. Erregierre SpA Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 126. Erregierre SpA Main Business
Table 127. Erregierre SpA Latest Developments
Table 128. CTX Lifescience Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 129. CTX Lifescience Mesalamine API Product Portfolios and Specifications
Table 130. CTX Lifescience Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 131. CTX Lifescience Main Business
Table 132. CTX Lifescience Latest Developments
Table 133. Ishita Active Pharma Ingredients Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 134. Ishita Active Pharma Ingredients Mesalamine API Product Portfolios and Specifications
Table 135. Ishita Active Pharma Ingredients Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 136. Ishita Active Pharma Ingredients Main Business
Table 137. Ishita Active Pharma Ingredients Latest Developments
Table 138. YC Biotech (Jiangsu) Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 139. YC Biotech (Jiangsu) Mesalamine API Product Portfolios and Specifications
Table 140. YC Biotech (Jiangsu) Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 141. YC Biotech (Jiangsu) Main Business
Table 142. YC Biotech (Jiangsu) Latest Developments
Table 143. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 144. Xinxiang Tianfeng Fine Chemical Mesalamine API Product Portfolios and Specifications
Table 145. Xinxiang Tianfeng Fine Chemical Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 146. Xinxiang Tianfeng Fine Chemical Main Business
Table 147. Xinxiang Tianfeng Fine Chemical Latest Developments
Table 1. Mesalamine API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mesalamine API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity ? 97 %
Table 4. Major Players of Purity ? 98 %
Table 5. Major Players of Purity ? 99 %
Table 6. Global Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 7. Global Mesalamine API Sales Market Share by Type (2020-2025)
Table 8. Global Mesalamine API Revenue by Type (2020-2025) & ($ million)
Table 9. Global Mesalamine API Revenue Market Share by Type (2020-2025)
Table 10. Global Mesalamine API Sale Price by Type (2020-2025) & (US$/kg)
Table 11. Global Mesalamine API Sale by Application (2020-2025) & (Tons)
Table 12. Global Mesalamine API Sale Market Share by Application (2020-2025)
Table 13. Global Mesalamine API Revenue by Application (2020-2025) & ($ million)
Table 14. Global Mesalamine API Revenue Market Share by Application (2020-2025)
Table 15. Global Mesalamine API Sale Price by Application (2020-2025) & (US$/kg)
Table 16. Global Mesalamine API Sales by Company (2020-2025) & (Tons)
Table 17. Global Mesalamine API Sales Market Share by Company (2020-2025)
Table 18. Global Mesalamine API Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Mesalamine API Revenue Market Share by Company (2020-2025)
Table 20. Global Mesalamine API Sale Price by Company (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Mesalamine API Producing Area Distribution and Sales Area
Table 22. Players Mesalamine API Products Offered
Table 23. Mesalamine API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalamine API Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Mesalamine API Sales Market Share Geographic Region (2020-2025)
Table 28. Global Mesalamine API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Mesalamine API Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Mesalamine API Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Mesalamine API Sales Market Share by Country/Region (2020-2025)
Table 32. Global Mesalamine API Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Mesalamine API Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Mesalamine API Sales by Country (2020-2025) & (Tons)
Table 35. Americas Mesalamine API Sales Market Share by Country (2020-2025)
Table 36. Americas Mesalamine API Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 38. Americas Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 39. APAC Mesalamine API Sales by Region (2020-2025) & (Tons)
Table 40. APAC Mesalamine API Sales Market Share by Region (2020-2025)
Table 41. APAC Mesalamine API Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 43. APAC Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 44. Europe Mesalamine API Sales by Country (2020-2025) & (Tons)
Table 45. Europe Mesalamine API Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 47. Europe Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Mesalamine API Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Mesalamine API Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Mesalamine API Sales by Type (2020-2025) & (Tons)
Table 51. Middle East & Africa Mesalamine API Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalamine API
Table 53. Key Market Challenges & Risks of Mesalamine API
Table 54. Key Industry Trends of Mesalamine API
Table 55. Mesalamine API Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalamine API Distributors List
Table 58. Mesalamine API Customer List
Table 59. Global Mesalamine API Sales Forecast by Region (2026-2031) & (Tons)
Table 60. Global Mesalamine API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Mesalamine API Sales Forecast by Country (2026-2031) & (Tons)
Table 62. Americas Mesalamine API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Mesalamine API Sales Forecast by Region (2026-2031) & (Tons)
Table 64. APAC Mesalamine API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Mesalamine API Sales Forecast by Country (2026-2031) & (Tons)
Table 66. Europe Mesalamine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Mesalamine API Sales Forecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Mesalamine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Mesalamine API Sales Forecast by Type (2026-2031) & (Tons)
Table 70. Global Mesalamine API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Mesalamine API Sales Forecast by Application (2026-2031) & (Tons)
Table 72. Global Mesalamine API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. PharmaZell Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 74. PharmaZell Mesalamine API Product Portfolios and Specifications
Table 75. PharmaZell Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 76. PharmaZell Main Business
Table 77. PharmaZell Latest Developments
Table 78. Syntese A/S Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 79. Syntese A/S Mesalamine API Product Portfolios and Specifications
Table 80. Syntese A/S Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Syntese A/S Main Business
Table 82. Syntese A/S Latest Developments
Table 83. Cambrex Corporation Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Corporation Mesalamine API Product Portfolios and Specifications
Table 85. Cambrex Corporation Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 86. Cambrex Corporation Main Business
Table 87. Cambrex Corporation Latest Developments
Table 88. Divis Laboratories Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 89. Divis Laboratories Mesalamine API Product Portfolios and Specifications
Table 90. Divis Laboratories Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 91. Divis Laboratories Main Business
Table 92. Divis Laboratories Latest Developments
Table 93. Chemi SpA Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemi SpA Mesalamine API Product Portfolios and Specifications
Table 95. Chemi SpA Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 96. Chemi SpA Main Business
Table 97. Chemi SpA Latest Developments
Table 98. Ipca Laboratories Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 99. Ipca Laboratories Mesalamine API Product Portfolios and Specifications
Table 100. Ipca Laboratories Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 101. Ipca Laboratories Main Business
Table 102. Ipca Laboratories Latest Developments
Table 103. Hangzhou Brother Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Brother Mesalamine API Product Portfolios and Specifications
Table 105. Hangzhou Brother Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 106. Hangzhou Brother Main Business
Table 107. Hangzhou Brother Latest Developments
Table 108. Lianyungang Fengheng Biopharm Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 109. Lianyungang Fengheng Biopharm Mesalamine API Product Portfolios and Specifications
Table 110. Lianyungang Fengheng Biopharm Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 111. Lianyungang Fengheng Biopharm Main Business
Table 112. Lianyungang Fengheng Biopharm Latest Developments
Table 113. Lasa Loboratory Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 114. Lasa Loboratory Mesalamine API Product Portfolios and Specifications
Table 115. Lasa Loboratory Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 116. Lasa Loboratory Main Business
Table 117. Lasa Loboratory Latest Developments
Table 118. Corden Pharma Bergamo Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 119. Corden Pharma Bergamo Mesalamine API Product Portfolios and Specifications
Table 120. Corden Pharma Bergamo Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 121. Corden Pharma Bergamo Main Business
Table 122. Corden Pharma Bergamo Latest Developments
Table 123. Erregierre SpA Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 124. Erregierre SpA Mesalamine API Product Portfolios and Specifications
Table 125. Erregierre SpA Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 126. Erregierre SpA Main Business
Table 127. Erregierre SpA Latest Developments
Table 128. CTX Lifescience Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 129. CTX Lifescience Mesalamine API Product Portfolios and Specifications
Table 130. CTX Lifescience Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 131. CTX Lifescience Main Business
Table 132. CTX Lifescience Latest Developments
Table 133. Ishita Active Pharma Ingredients Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 134. Ishita Active Pharma Ingredients Mesalamine API Product Portfolios and Specifications
Table 135. Ishita Active Pharma Ingredients Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 136. Ishita Active Pharma Ingredients Main Business
Table 137. Ishita Active Pharma Ingredients Latest Developments
Table 138. YC Biotech (Jiangsu) Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 139. YC Biotech (Jiangsu) Mesalamine API Product Portfolios and Specifications
Table 140. YC Biotech (Jiangsu) Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 141. YC Biotech (Jiangsu) Main Business
Table 142. YC Biotech (Jiangsu) Latest Developments
Table 143. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalamine API Manufacturing Base, Sales Area and Its Competitors
Table 144. Xinxiang Tianfeng Fine Chemical Mesalamine API Product Portfolios and Specifications
Table 145. Xinxiang Tianfeng Fine Chemical Mesalamine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 146. Xinxiang Tianfeng Fine Chemical Main Business
Table 147. Xinxiang Tianfeng Fine Chemical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mesalamine API
Figure 2. Mesalamine API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalamine API Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Mesalamine API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mesalamine API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mesalamine API Sales Market Share by Country/Region (2024)
Figure 10. Mesalamine API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity ? 97 %
Figure 12. Product Picture of Purity ? 98 %
Figure 13. Product Picture of Purity ? 99 %
Figure 14. Global Mesalamine API Sales Market Share by Type in 2025
Figure 15. Global Mesalamine API Revenue Market Share by Type (2020-2025)
Figure 16. Mesalamine API Consumed inTablets
Figure 17. Global Mesalamine API Market:Tablets (2020-2025) & (Tons)
Figure 18. Mesalamine API Consumed in Capsules
Figure 19. Global Mesalamine API Market: Capsules (2020-2025) & (Tons)
Figure 20. Mesalamine API Consumed in Granule
Figure 21. Global Mesalamine API Market: Granule (2020-2025) & (Tons)
Figure 22. Mesalamine API Consumed in Suppository
Figure 23. Global Mesalamine API Market: Suppository (2020-2025) & (Tons)
Figure 24. Mesalamine API Consumed in Enema
Figure 25. Global Mesalamine API Market: Enema (2020-2025) & (Tons)
Figure 26. Mesalamine API Consumed in Others
Figure 27. Global Mesalamine API Market: Others (2020-2025) & (Tons)
Figure 28. Global Mesalamine API Sale Market Share by Application (2024)
Figure 29. Global Mesalamine API Revenue Market Share by Application in 2025
Figure 30. Mesalamine API Sales by Company in 2025 (Tons)
Figure 31. Global Mesalamine API Sales Market Share by Company in 2025
Figure 32. Mesalamine API Revenue by Company in 2025 ($ millions)
Figure 33. Global Mesalamine API Revenue Market Share by Company in 2025
Figure 34. Global Mesalamine API Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Mesalamine API Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Mesalamine API Sales 2020-2025 (Tons)
Figure 37. Americas Mesalamine API Revenue 2020-2025 ($ millions)
Figure 38. APAC Mesalamine API Sales 2020-2025 (Tons)
Figure 39. APAC Mesalamine API Revenue 2020-2025 ($ millions)
Figure 40. Europe Mesalamine API Sales 2020-2025 (Tons)
Figure 41. Europe Mesalamine API Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Mesalamine API Sales 2020-2025 (Tons)
Figure 43. Middle East & Africa Mesalamine API Revenue 2020-2025 ($ millions)
Figure 44. Americas Mesalamine API Sales Market Share by Country in 2025
Figure 45. Americas Mesalamine API Revenue Market Share by Country (2020-2025)
Figure 46. Americas Mesalamine API Sales Market Share by Type (2020-2025)
Figure 47. Americas Mesalamine API Sales Market Share by Application (2020-2025)
Figure 48. United States Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Mesalamine API Sales Market Share by Region in 2025
Figure 53. APAC Mesalamine API Revenue Market Share by Region (2020-2025)
Figure 54. APAC Mesalamine API Sales Market Share by Type (2020-2025)
Figure 55. APAC Mesalamine API Sales Market Share by Application (2020-2025)
Figure 56. China Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 60. India Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Mesalamine API Sales Market Share by Country in 2025
Figure 64. Europe Mesalamine API Revenue Market Share by Country (2020-2025)
Figure 65. Europe Mesalamine API Sales Market Share by Type (2020-2025)
Figure 66. Europe Mesalamine API Sales Market Share by Application (2020-2025)
Figure 67. Germany Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 68. France Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Mesalamine API Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Mesalamine API Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Mesalamine API Sales Market Share by Application (2020-2025)
Figure 75. Egypt Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Mesalamine API in 2025
Figure 81. Manufacturing Process Analysis of Mesalamine API
Figure 82. Industry Chain Structure of Mesalamine API
Figure 83. Channels of Distribution
Figure 84. Global Mesalamine API Sales Market Forecast by Region (2026-2031)
Figure 85. Global Mesalamine API Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Mesalamine API Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Mesalamine API Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Mesalamine API Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Mesalamine API Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Mesalamine API
Figure 2. Mesalamine API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalamine API Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Mesalamine API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mesalamine API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mesalamine API Sales Market Share by Country/Region (2024)
Figure 10. Mesalamine API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity ? 97 %
Figure 12. Product Picture of Purity ? 98 %
Figure 13. Product Picture of Purity ? 99 %
Figure 14. Global Mesalamine API Sales Market Share by Type in 2025
Figure 15. Global Mesalamine API Revenue Market Share by Type (2020-2025)
Figure 16. Mesalamine API Consumed inTablets
Figure 17. Global Mesalamine API Market:Tablets (2020-2025) & (Tons)
Figure 18. Mesalamine API Consumed in Capsules
Figure 19. Global Mesalamine API Market: Capsules (2020-2025) & (Tons)
Figure 20. Mesalamine API Consumed in Granule
Figure 21. Global Mesalamine API Market: Granule (2020-2025) & (Tons)
Figure 22. Mesalamine API Consumed in Suppository
Figure 23. Global Mesalamine API Market: Suppository (2020-2025) & (Tons)
Figure 24. Mesalamine API Consumed in Enema
Figure 25. Global Mesalamine API Market: Enema (2020-2025) & (Tons)
Figure 26. Mesalamine API Consumed in Others
Figure 27. Global Mesalamine API Market: Others (2020-2025) & (Tons)
Figure 28. Global Mesalamine API Sale Market Share by Application (2024)
Figure 29. Global Mesalamine API Revenue Market Share by Application in 2025
Figure 30. Mesalamine API Sales by Company in 2025 (Tons)
Figure 31. Global Mesalamine API Sales Market Share by Company in 2025
Figure 32. Mesalamine API Revenue by Company in 2025 ($ millions)
Figure 33. Global Mesalamine API Revenue Market Share by Company in 2025
Figure 34. Global Mesalamine API Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Mesalamine API Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Mesalamine API Sales 2020-2025 (Tons)
Figure 37. Americas Mesalamine API Revenue 2020-2025 ($ millions)
Figure 38. APAC Mesalamine API Sales 2020-2025 (Tons)
Figure 39. APAC Mesalamine API Revenue 2020-2025 ($ millions)
Figure 40. Europe Mesalamine API Sales 2020-2025 (Tons)
Figure 41. Europe Mesalamine API Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Mesalamine API Sales 2020-2025 (Tons)
Figure 43. Middle East & Africa Mesalamine API Revenue 2020-2025 ($ millions)
Figure 44. Americas Mesalamine API Sales Market Share by Country in 2025
Figure 45. Americas Mesalamine API Revenue Market Share by Country (2020-2025)
Figure 46. Americas Mesalamine API Sales Market Share by Type (2020-2025)
Figure 47. Americas Mesalamine API Sales Market Share by Application (2020-2025)
Figure 48. United States Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Mesalamine API Sales Market Share by Region in 2025
Figure 53. APAC Mesalamine API Revenue Market Share by Region (2020-2025)
Figure 54. APAC Mesalamine API Sales Market Share by Type (2020-2025)
Figure 55. APAC Mesalamine API Sales Market Share by Application (2020-2025)
Figure 56. China Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 60. India Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Mesalamine API Sales Market Share by Country in 2025
Figure 64. Europe Mesalamine API Revenue Market Share by Country (2020-2025)
Figure 65. Europe Mesalamine API Sales Market Share by Type (2020-2025)
Figure 66. Europe Mesalamine API Sales Market Share by Application (2020-2025)
Figure 67. Germany Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 68. France Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Mesalamine API Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Mesalamine API Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Mesalamine API Sales Market Share by Application (2020-2025)
Figure 75. Egypt Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Mesalamine API Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Mesalamine API in 2025
Figure 81. Manufacturing Process Analysis of Mesalamine API
Figure 82. Industry Chain Structure of Mesalamine API
Figure 83. Channels of Distribution
Figure 84. Global Mesalamine API Sales Market Forecast by Region (2026-2031)
Figure 85. Global Mesalamine API Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Mesalamine API Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Mesalamine API Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Mesalamine API Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Mesalamine API Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Monofilament Fishing Line Market Growth 2025-2031
US$ 3,660.00
December 2024
110 pages
Global Thiophene Market Growth 2025-2031
US$ 3,660.00
January 2025
88 pages
